Newsroom
-
June 22 , 2021
Scientists discover novel oncogenic driver gene in human lung cancer
- A research team led by Prof. Wang Yuexiang from the Shanghai Institute of Nutrition and Health (SINH) of the Chinese Academy of Sciences discovered a novel oncogenic driver gene in human lung cancer, the leading cause of cancer-related mortality worldwide.
Read more -
June 21 , 2021
SARS-CoV-2 infections may trigger antibody responses against multiple virus proteins
- A study published in PLOS Biology by Anna Heffron, Irene Ong and colleagues at the University of Wisconsin-Madison, U.S., suggests that immune responses may develop against other proteins produced by the SARS-CoV-2 virus.
Read more -
June 18 , 2021
Next-generation T-cell therapeutics set sights on cancers, autoimmune disorders and more
- T cells—immune cells that patrol our bodies in search of trouble—have become a central focus for UC San Francisco scientists working on living cell therapies, an approach that views cells themselves as a form of medicine.
Read more -
June 17 , 2021
Most cancer cells grown in a dish have little in common with cancer cells in people
- In a bid to find or refine laboratory research models for cancer that better compare with what happens in living people, Johns Hopkins Medicine scientists report they have developed a new computer-based technique showing that human cancer cells grown in culture dishes are the least genetically similar to their human sources.
Read more -
June 16 , 2021
Scientists are deciphering the details of immune cell activation
- Chemokine receptors, located at the surface of many immune cells, play an important role in cell function. Chemokines are small proteins that bind to these receptors and control the movement and behavior of white blood cells.
Read more -
June 16 , 2021
Small number of cells could be key enablers of cancer metastasis
- Just a small number of cells found in tumors can enable and recruit other types of cells nearby, allowing the cancer to spread to other parts of the body, report Georgetown Lombardi Comprehensive Cancer Center scientists. Working with their research collaborators, the scientists found that 'enabler cells' comprise about 20 percent or less of the cells in an
Read more -
June 16 , 2021
P-glycoprotein removes Alzheimer's-associated toxin from the brain
- A team of SMU biological scientists has confirmed that P-glycoprotein (P-gp) has the ability to remove from the brain a toxin that is associated with Alzheimer's disease.
Read more -
June 15 , 2021
Researchers discover that a protein that facilitates DNA repair may enhance chemotherapy
- CNIO researchers have found out how the cell does that and plan to use this knowledge to enhance cancer treatments.
Read more -
June 15 , 2021
Novel radiopharmaceutical tracks 'master switch' protein responsible for cancer growth
- A protein that is critical in cancer cell metabolism has been imaged for the first time with a newly developed radiopharmaceutical, 18F-DASA-23. Imaging with this novel agent has the potential to improve the assessment of treatment response for patients, specifically those with brain tumors. This study was presented at the Society of Nuclear Medicine and Mol
Read more -
June 15 , 2021
Study reveals new pathway for brain tumor therapy
- In a new study led by Yale Cancer Center, researchers show the nucleoside transporter ENT2 may offer an unexpected path to circumventing the blood-brain barrier (BBB) and enabling targeted treatment of brain tumors with a cell-penetrating anti-DNA autoantibody. The study was published today online in the Journal of Clinical Investigation Insight.
Read more -
June 14 , 2021
A new model of Alzheimer's progression
- Alzheimer's disease is the most common form of dementia and is characterized by neurodegeneration in regions of the brain involved in memory and learning. Amyloid beta and tau are two toxic proteins that build up in disease and cause eventual neuronal death, but little is known about how other cells in the brain react during disease progression.
Read more -
June 14 , 2021
New gene therapy uses Tylenol to combat genetic diseases
- Researchers have developed a new approach to gene therapy that leans on the common pain reliever acetaminophen to force a variety of genetic diseases into remission.
Read more